INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2008

Cyanocobalamin treatment reduced recurrent aphthous ulcer frequency in patients with both deficient and normal baseline vitamin B12 levels.

Seventy-two patients with recurrent aphthous ulcers were assigned to a cyanocobalamin treatment protocol and categorized as cobalamin deficient (<140 pg/mL, n=37) or normal (≥140 pg/mL, n=35). At baseline, serum cobalamin was 107.43 ± 29.35 pg/mL in the deficient group and 215.8 ± 116.90 pg/mL in the normal group, with baseline monthly ulcer frequencies of 2.4 ± 0.9 and 1.9 ± 0.7, respectively. Following treatment, both groups showed significant increases in cobalamin levels and significant decreases in ulcer frequency. Overall, 96% of participants showed a good response to replacement treatment, while 4% did not respond.

Study type
Interventional trial
Who was studied
72 patients with recurrent aphthous ulcers (37 cobalamin deficient, 35 normal)
What was measured
Aphthous ulcer healing/frequency and serum cobalamin levels at months 1 and 6

THE PAPER

Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal.

Gulcan E, Toker S, Hatipoğlu H, Gulcan A, Toker A. Am J Med Sci, 2008.

PubMed 19011392 ↗DOI 10.1097/maj.0b013e31816a05f2 ↗

Nutrients & adequacyOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.